Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Tags:
Novartis
,
Sandoz
,
biosimilars
,
generics
,
women executives
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Tags:
Novartis
,
Sandoz
,
Evotec
,
biosimilars
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Tags:
Biogen
,
Novartis
,
Sanofi
,
earnings
,
R&D
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Thu, 05/4/23 - 09:00 pm
Tags:
Novartis
,
Sandoz
,
generics
,
Adalvo
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Tags:
Europe
,
M&A
,
GSK
,
Novartis
,
Roche
Novartis’s iptacopan meets primary endpoint in Phase III PNH trial
Clinical Trials Arena
Thu, 04/27/23 - 10:30 am
Tags:
Novartis
,
clinical trials
,
PNH
,
iptacopan
Bristol Myers boosts cell therapy production with Novartis plant
BioPharma Dive
Wed, 04/26/23 - 05:40 pm
Tags:
Bristol Myers Squibb
,
cell therapy
,
Novartis
,
drug manufacturing
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
BioSpace
Wed, 04/26/23 - 10:24 am
Tags:
Novartis
,
earnings
,
solid tumors
,
hematology
,
immunology
,
Neuroscience
,
cardiovascular disease
Point looks to turn the tables on Novartis
EP Vantage
Wed, 04/26/23 - 09:55 am
Tags:
Novartis
,
Point Biopharma
,
radiopharmaceuticals
Novartis, helped by cost cuts, raises full-year outlook
Reuters
Tue, 04/25/23 - 10:47 am
Tags:
Novartis
,
earnings
Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology
Medical Marketing and Media
Tue, 04/25/23 - 10:32 am
Tags:
Novartis
,
3B Pharmaceuticals
,
FAP-targeting peptides
Novartis plant cleared to produce in-demand cancer drug
BioPharma Dive
Mon, 04/24/23 - 10:59 pm
Tags:
Novartis
,
drug manufacturing
,
Pluvicto
,
New Jersey
,
cancer
,
radiopharmaceuticals
FDA again delays Daiichi's plans to challenge Astellas and Novartis for blood cancer market
Fierce Biotech
Fri, 04/21/23 - 10:08 am
Tags:
Daiichi Sankyo
,
Astellas
,
Novartis
,
quizartinib
,
FDA
,
blood cancer
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A
,
R&D
,
AbbVie
,
AstraZeneca
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
JNJ
,
Merck
,
Novartis
,
Pfizer
,
Roche
,
Sanofi
AACR 2023 – Hippo makes a splash
EP Vantage
Wed, 04/19/23 - 10:07 am
Tags:
Vivace Therapeutics
,
VT3989
,
AACR
,
Novartis
,
Sanofi
,
Ikena Oncology
Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi
Fierce Pharma
Tue, 04/18/23 - 09:58 am
Tags:
legal
,
Supreme Court
,
Novartis
,
Gilenya
,
Sanofi
,
Viatris
,
EpiPens
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Tue, 04/11/23 - 10:04 am
Tags:
Novartis
,
Cosentyx
,
AbbVie
,
Humira
,
hidradenitis suppurativa
,
UCB Pharma
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.